Research Director at the CNRS within the Stem Cell and Brain Research Institute (SBRI), Inserm U1208, University of Lyon and Co-Founder, in 2009, of the Joint Laboratory on Neuropathogenesis along with Prof. Chonggang YUAN at East China Normal University (ECNU) in Shanghai, integrated into the Key Laboratory of Brain Functional Genomics at the ECNU in January 2014. The main objective is the transfer of fundamental discoveries using small antibody mimetics called peptide aptamers, to potential patient benefit in the context of the StemGamE platform. The present transfer focus: • neurodegenerative diseases - e.g. ALS (Amyotrophic Lateral Sclerosis - Maladie de Charcot) • stimulation of the immune response e.g. for adoptive cell therapy of certain cancers • enhancement of safety of the use of embryonic stem cell-derived cultures for potential therapeutic benefit.
|2004||70(4):1147-52||Key role for cyclin-dependent kinases in the first and second meiotic divisions of rat spermatocytes||Godet M, Damestoy A, Mouradian S, Rudkin BB, Durand P||Biol Reprod|
|2000||79(11):816-23||Developmental changes in cyclin B1 and cyclin-dependent kinase 1 (CDK1) levels in the different populations of spermatogenic cells of the post-natal rat testis||Godet M, Thomas A, Rudkin BB, Durand P||Eur J Cell Biol|
|1996||12(2):309-22||Withdrawal of differentiation inhibitory activity/leukemia inhibitory factor up-regulates D-type cyclins and cyclin-dependent kinase inhibitors in mouse embryonic stem cells||Savatier P, Lapillonne H, van Grunsven LA, Rudkin BB, Samarut J||Oncogene|
|1996||12(6):1347-56||Effect of nerve growth factor on the expression of cell cycle regulatory proteins in PC12 cells: dissection of the neurotrophic response from the anti-mitogenic response||van Grunsven LA, Billon N, Savatier P, Thomas A, Urdiales JL, Rudkin BB||Oncogene|